| [1] |
Zheng R, Zhang S, Zeng H, et al. Cancer incidence and mortality in China, 2016[J]. J Natl Cancer Cent, 2022, 2:1-9.
|
| [2] |
Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71:209-249.
|
| [3] |
Scheeren FA, Kuo AH, van Weele LJ, et al. A cell-intrinsic role for TLR2-MYD88 in intestinal and breast epithelia and oncogenesis[J]. Nat Cell Biol, 2014, 16:1238-1248.
|
| [4] |
Martínez A, Bono C, Gozalbo D, et al. TLR2 and dectin-1 signaling in mouse hematopoietic stem and progenitor cells impacts the ability of the antigen presenting cells they produce to activate CD4 T cells[J]. Cells, 2020, 9:1317.doi:10.3390/cells9051317.
|
| [5] |
Su YR, Chen MT, Xiong K, et al. Endogenous Toll-like receptor 2 modulates Th1/Treg-promoting dendritic cells in mice corneal transplantation model[J]. Curr Eye Res, 2020, 45:774-781.
|
| [6] |
Nakao M, Sugaya M, Fujita H, et al. TLR2 deficiency exacerbates imiquimod-induced psoriasis-like skin inflammation through decrease in regulatory T cells and impaired IL-10 production[J]. Int J Mol Sci, 2020, 21:8560.doi:10.3390/ijms21228560.
|
| [7] |
Im J, Baik JE, Lee D, et al. Bacterial lipoproteins induce BAFF production via TLR2/MyD88/JNK signaling pathways in dendritic cells[J]. Front Immunol, 2020, 11:564699.doi:10.3389/fimmu.2020.564699.
|
| [8] |
Mccoy MG, Nascimento DW, Veleeparambil M, et al. Endothelial TLR2 promotes proangiogenic immune cell recruitment and tumor angiogenesis[J]. Sci Signal, 2021, 14:eabc5371.doi:10.1126/scisignal.abc5371.
|
| [9] |
Lundy J, Gearing LJ, Gao H, et al. TLR2 activation promotes tumour growth and associates with patient survival and chemotherapy response in pancreatic ductal adenocarcinoma[J]. Oncogene, 2021, 40:6007-6022.
|
| [10] |
Fan L, Xu C, Ge Q, et al. A. Muciniphila suppresses colorectal tumorigenesis by inducing TLR2/NLRP3-Mediated M1-like TAMs[J]. Cancer Immunol Res, 2021, 9:1111-1124.
|
| [11] |
Xu J, Guo R, Jia J, et al. Activation of Toll-like receptor 2 enhances peripheral and tumor-infiltrating CD8(+) T cell cytotoxicity in patients with gastric cancer[J]. BMC Immunol, 2021, 22:67.doi:10.1186/s12865-021-00459-z.
|
| [12] |
Chang YJ, Wu MS, Lin JT, et al. Helicobacter pylori-induced invasion and angiogenesis of gastric cells is mediated by cyclooxygenase-2 induction through TLR2/TLR9 and promoter regulation[J]. J Immunol, 2005, 175:8242-8252.
|
| [13] |
Zhu G, Cheng Z, Huang Y, et al. MyD88 mediates colorectal cancer cell proliferation, migration and invasion via NF-κB/AP-1 signaling pathway[J]. Int J Mol Med, 2020, 45:131-140.
|
| [14] |
Xu Z, Lv Z, Chen F, et al. Dysbiosis of human tumor microbiome and aberrant residence of actinomyces in tumor-associated fibroblasts in young-onset colorectal cancer[J]. Front Immunol, 2022, 13:1008975.doi:10.3389/fimmu.2022.1008975.
|
| [15] |
Liu YD, Ji CB, Li SB, et al. Toll-like receptor 2 stimulation promotes colorectal cancer cell growth via PI3K/Akt and NF-κB signaling pathways[J]. Int Immunopharmacol, 2018, 59:375-383.
|
| [16] |
Chen X, Zhang L, Jiang Y, et al. Radiotherapy-induced cell death activates paracrine HMGB1-TLR2 signaling and accelerates pancreatic carcinoma metastasis[J]. J Exp Clin Cancer Res, 2018, 37:77.doi:10.1186/s13046-018-0726-2.
|
| [17] |
Kajino-Sakamoto R, Fujishita T, Taketo MM, et al. Synthetic lethality between MyD88 loss and mutations in Wnt/β-catenin pathway in intestinal tumor epithelial cells[J]. Oncogene, 2021, 40:408-420.
|
| [18] |
Tang F, Cao F, Lu C, et al. Dvl2 facilitates the coordination of NF-κB and Wnt signaling to promote colitis-associated colorectal progression[J]. Cancer Sci, 2022, 113:565-575.
|
| [19] |
Zhang S, Wang J, Chen T, et al. α-Actinin1 promotes tumorigenesis and epithelial-mesenchymal transition of gastric cancer via the Akt/GSK3β/β-Catenin pathway[J]. Bioengineered, 2021, 12:5688-5704.
|
| [20] |
Gao L, Wang TH, Chen CP, et al. Targeting COX-2 potently inhibits proliferation of cancer cells in vivo but not in vitro in cutaneous squamous cell carcinoma[J]. Transl Cancer Res, 2021, 10:2219-2228.
|
| [21] |
Ma J, Zhang C, Liang W, et al. ω-3 and ω-6 polyunsaturated fatty acids regulate the proliferation, invasion and angiogenesis of gastric cancer through COX/PGE signaling pathway[J]. Front Oncol, 2022, 12:802009.doi:10.3389/fonc.2022.802009.
|
| [22] |
Wu L, Sun J, Liu L, et al. Anti-toll-like receptor 2 antibody ameliorates hepatic injury, inflammation, fibrosis and steatosis in obesity-related metabolic disorder rats via regulating MAPK and NF-κB pathways[J]. Int Immunopharmacol, 2020, 82:106368.doi:10.1016/j.intimp.2020.106368.
|
| [23] |
Khedr OMS, El-Sonbaty SM, Moawed FSM, et al. Lactobacillus acidophilus ATCC 4356 exopolysaccharides suppresses mediators of inflammation through the inhibition of TLR2/STAT-3/P38-MAPK pathway in DEN-induced hepatocarcinogenesis in rats[J]. Nutr Cancer, 2022, 74:1037-1047.
|
| [24] |
Xie X, Lv H, Liu C, et al. HBeAg mediates inflammatory functions of macrophages by TLR2 contributing to hepatic fibrosis[J]. BMC Med, 2021, 19:247.doi:10.1186/s12916-021-02085-3.
|
| [25] |
Tsoi H, Chu ESH, Zhang X, et al. Peptostreptococcus anaerobius induces intracellular cholesterol biosynthesis in colon cells to induce proliferation and causes dysplasia in mice[J]. Gastroenterology, 2017, 152:1419-1433.
|
| [26] |
Li S, Li F, Xu L, et al. TLR2 agonist promotes myeloid-derived suppressor cell polarization via Runx1 in hepatocellular carcinoma[J]. Int Immunopharmacol, 2022, 111:109168.doi:10.1016/j.intimp.2022.109168.
|
| [27] |
Bermudez M, Grabowski M, Murgueitio MS, et al. Biological characterization, mechanistic investigation and structure-activity relationships of chemically stable TLR2 antagonists[J]. Chem Med Chem, 2020, 15:1364-1371.
|
